Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 15, 2023
April 11, 2024
282489cf-c0a6-44c7-acff-58b3373fd179
Related Documents
Considerations When Transferring Clinical Investigation Oversight to Another IRB: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentMay 23, 2014Office of the Commissioner
Principles of Premarket Pathways for Combination Products: Guidance for Industry and FDA Staff
Guidance DocumentJanuary 26, 2022Office of the Commissioner
Postmarketing Safety Reporting for Combination Products: Guidance for Industry and FDA Staff
Guidance DocumentJuly 22, 2019Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox